Grant: Discovery Grants Program - Individual
The University of British Columbia
$28,000.00
Characterizing the role CSF1R-expressing cells play in craniofacial development
EF 2024-25
Résumé
Colony-stimulating factor-1 receptor (CSF1R) is expressed by numerous phagocytic cells, including microglia, macrophages, and osteoclasts, and is required for their proliferation, differentiation, and survival. In mice, Csf1r knockout causes increased bone density, a toothless phenotype, growth retardation, CNS disruptions, and perinatal mortality. These germline knockouts suggest CSF1R-expressing cells have embryonic functions, but other means of transiently disrupting these cells is required to address their gestational roles. Accordingly, we established a pharmacological depletion model whereby the CSF1R inhibitor PLX5622 is fed to pregnant mice starting at E3.5 and continued until birth. We show that PLX5622-exposure across gestation results in craniofacial and dental abnormalities. These robust phenotypes are novel and have not yet been examined. The long-term objective of my research program is to understand the mechanisms through which phagocytic immune cells contribute to the normal development of the embryo. In the short-term, the proposed work will focus on characterizing craniofacial macrophage and osteoclast heterogeneity during embryogenesis and determining how depleting these cells amid gestation impacts craniofacial development. We hypothesize that CSF1R-expressing cells reside in a spatially restricted pattern across craniofacial tissues, and it is through interactions with surrounding cells that the phenotypic disruptions observed are produced.
Using our pharmacological depletion mouse model, we will determine how the CSF1R inhibitor PLX5622 impacts macrophages and osteoclasts across embryogenesis and define the craniofacial phenotypes that result from depleting these CSF1R+ cells during gestation in Aim 1. To start, we will use IHC to study how PLX5622-exposure impacts macrophage and osteoclast proliferation and survival across craniofacial tissues. We will then examine how depleting these cells impacts the developing nerves and muscles in the head of these animals using IHC, and use micro-CT to visualize craniofacial shape changes. In Aim 2, we will characterize macrophage and osteoclast heterogeneity during embryogenesis and define the spatiotemporal expression of discrete populations by isolating CSF1R-expressing cells for single-cell RNA sequencing. Bioinformatic analysis of the resulting datasets will allow us to characterize macrophage and osteoclast heterogeneity across craniofacial tissues, which will be validated using FISH and IHC. In Aim 3, we will study the signalling effects of CSF1R-expressing cells during craniofacial development by analyzing changes in secreted factors between control and PLX5622-exposed craniofacial tissues, and apply these same factors to neural crest-derived spheres in cultures to assess their impact on proliferation and/or differentiation. These studies are important because they will provide novel insights into how CSF1R-expressing phagocytes contribute to normal craniofacial development.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2022-03718
Name nom
Rosin, Jessica
Department département
Department of Oral Biological and Medical Sciences
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Characterizing the role CSF1R-expressing cells play in craniofacial development
Keywords
development; embryogenesis; craniofacial morphogenesis; colony-stimulating factor-1 receptor (csf1r); macrophages; osteoclasts; single-cell rna sequencing (scrnaseq); bone; nerves; muscles
Application summary
Colony-stimulating factor-1 receptor (CSF1R) is expressed by numerous phagocytic cells, including microglia, macrophages, and osteoclasts, and is required for their proliferation, differentiation, and survival. In mice, Csf1r knockout causes increased bone density, a toothless phenotype, growth retardation, CNS disruptions, and perinatal mortality. These germline knockouts suggest CSF1R-expressing cells have embryonic functions, but other means of transiently disrupting these cells is required to address their gestational roles. Accordingly, we established a pharmacological depletion model whereby the CSF1R inhibitor PLX5622 is fed to pregnant mice starting at E3.5 and continued until birth. We show that PLX5622-exposure across gestation results in craniofacial and dental abnormalities. These robust phenotypes are novel and have not yet been examined. The long-term objective of my research program is to understand the mechanisms through which phagocytic immune cells contribute to the normal development of the embryo. In the short-term, the proposed work will focus on characterizing craniofacial macrophage and osteoclast heterogeneity during embryogenesis and determining how depleting these cells amid gestation impacts craniofacial development. We hypothesize that CSF1R-expressing cells reside in a spatially restricted pattern across craniofacial tissues, and it is through interactions with surrounding cells that the phenotypic disruptions observed are produced.
Using our pharmacological depletion mouse model, we will determine how the CSF1R inhibitor PLX5622 impacts macrophages and osteoclasts across embryogenesis and define the craniofacial phenotypes that result from depleting these CSF1R+ cells during gestation in Aim 1. To start, we will use IHC to study how PLX5622-exposure impacts macrophage and osteoclast proliferation and survival across craniofacial tissues. We will then examine how depleting these cells impacts the developing nerves and muscles in the head of these animals using IHC, and use micro-CT to visualize craniofacial shape changes. In Aim 2, we will characterize macrophage and osteoclast heterogeneity during embryogenesis and define the spatiotemporal expression of discrete populations by isolating CSF1R-expressing cells for single-cell RNA sequencing. Bioinformatic analysis of the resulting datasets will allow us to characterize macrophage and osteoclast heterogeneity across craniofacial tissues, which will be validated using FISH and IHC. In Aim 3, we will study the signalling effects of CSF1R-expressing cells during craniofacial development by analyzing changes in secreted factors between control and PLX5622-exposed craniofacial tissues, and apply these same factors to neural crest-derived spheres in cultures to assess their impact on proliferation and/or differentiation. These studies are important because they will provide novel insights into how CSF1R-expressing phagocytes contribute to normal craniofacial development.